{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:25:28Z","timestamp":1790810728378,"version":"4.1.0"},"reference-count":47,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,4,2]]},"published-print":{"date-parts":[[2026,8]]},"DOI":"10.2967\/jnumed.126.272191","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:55:12Z","timestamp":1778770512000},"page":"1201-1208","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Performance of FAPI PET in Patients with Breast Cancer: A Systematic Review"],"prefix":"10.2967","volume":"67","author":[{"given":"Lisa E.H.W.","family":"Duijx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia C.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Backhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bauwens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix M.","family":"Mottaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim E.","family":"Wildberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiemo J.A.","family":"van Nijnatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"2026082505101069000_67.8.1201.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026082505101069000_67.8.1201.2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40336-021-00426-z","article-title":"Breast cancer: initial workup and staging with FDG PET\/CT","volume":"9","author":"Groheux","year":"2021","journal-title":"Clin Transl Imaging."},{"key":"2026082505101069000_67.8.1201.3","unstructured":"Survival rates for breast cancer. American Cancer Society website. https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/breast-cancer-survival-rates.html. Accessed April 14, 2026."},{"key":"2026082505101069000_67.8.1201.4","doi-asserted-by":"crossref","first-page":"103806","DOI":"10.1016\/j.breast.2024.103806","article-title":"Role of [18F]FDG PET\/CT in patients with invasive breast carcinoma of no special type: literature review and comparison between guidelines","volume":"78","author":"Groheux","year":"2024","journal-title":"Breast."},{"key":"2026082505101069000_67.8.1201.5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13550-023-00953-y","article-title":"The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis","volume":"13","author":"de Mooij","year":"2023","journal-title":"EJNMMI Res."},{"key":"2026082505101069000_67.8.1201.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1640-9"},{"key":"2026082505101069000_67.8.1201.7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.854658"},{"key":"2026082505101069000_67.8.1201.8","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3390\/diagnostics13122018","article-title":"FAPI PET\/CT imaging\u2014an updated review","volume":"13","author":"Chandekar","year":"2023","journal-title":"Diagnostics (Basel)."},{"key":"2026082505101069000_67.8.1201.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262426"},{"key":"2026082505101069000_67.8.1201.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227967"},{"key":"2026082505101069000_67.8.1201.11","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1097\/RLU.0000000000004523","article-title":"68Ga-FAPI versus 18F-FDG PET\/CT in evaluating newly diagnosed breast cancer patients: a head-to-head comparative study","volume":"48","author":"Zheng","year":"2023","journal-title":"Clin Nucl Med."},{"key":"2026082505101069000_67.8.1201.12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12149-021-01616-5","article-title":"68Ga-FAPI-04 PET\/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET\/CT","volume":"35","author":"Komek","year":"2021","journal-title":"Ann Nucl Med."},{"key":"2026082505101069000_67.8.1201.13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s12149-021-01672-x","article-title":"Superiority of 68Ga-FAPI PET\/CT scan in detecting additional lesions compared to 18FDG PET\/CT scan in breast cancer","volume":"35","author":"Elboga","year":"2021","journal-title":"Ann Nucl Med."},{"key":"2026082505101069000_67.8.1201.14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.acra.2024.07.058","article-title":"Comparison of 18F-FDG PET\/CT and 18F-FAPI PET\/CT in systemic staging of newly diagnosed breast cancer","volume":"32","author":"Bin","year":"2025","journal-title":"Acad Radiol."},{"key":"2026082505101069000_67.8.1201.15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00259-025-07108-2","article-title":"FAP-targeted PET\/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management","volume":"52","author":"Guo","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026082505101069000_67.8.1201.16","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"2026082505101069000_67.8.1201.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135"},{"key":"2026082505101069000_67.8.1201.18","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183"},{"key":"2026082505101069000_67.8.1201.19","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031\/FULLARTICLE"},{"key":"2026082505101069000_67.8.1201.20","doi-asserted-by":"publisher","DOI":"10.1059\/0003-4819-155-8-201110180-00009"},{"key":"2026082505101069000_67.8.1201.21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/ph16040521","article-title":"Head-to-head comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET\/CT imaging in patients with breast cancer","volume":"16","author":"Ballal","year":"2023","journal-title":"Pharmaceuticals (Basel)."},{"key":"2026082505101069000_67.8.1201.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05132-y"},{"key":"2026082505101069000_67.8.1201.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266798"},{"key":"2026082505101069000_67.8.1201.24","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1097\/RLU.0000000000004751","article-title":"68Ga-FAPI-04 PET\/CT in selected breast cancer patients with low FDG affinity: a head-to-head comparative study","volume":"48","author":"Alcin","year":"2023","journal-title":"Clin Nucl Med."},{"key":"2026082505101069000_67.8.1201.25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40336-025-00739-3","article-title":"Comparison of 68Ga-FAPI PET\/CT and 18F-FDG PET\/CT for staging of the axillary lymph nodes in breast cancer patients","volume":"14","author":"Kalender","year":"2025","journal-title":"Clin Transl Imaging."},{"key":"2026082505101069000_67.8.1201.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264871"},{"key":"2026082505101069000_67.8.1201.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266079"},{"key":"2026082505101069000_67.8.1201.28","doi-asserted-by":"crossref","unstructured":"Oflas M Simsek DH Yilmaz R . The Schr\u00f6dinger\u2019s cat paradox: can MAMMI PET with 68Ga-FAPI determine pathological complete response to neoadjuvant chemotherapy in breast cancer omitting surgery? Cancer Biother Radiopharm. December 8, 2025 [Epub ahead of print].","DOI":"10.1177\/10849785251404410"},{"key":"2026082505101069000_67.8.1201.29","doi-asserted-by":"crossref","first-page":"100004","DOI":"10.1016\/j.eanmj.2025.100004","article-title":"European Association of Nuclear Medicine (EANM) focus meeting 6 consensus on molecular imaging in breast cancer (endorsed by EUSOBI, ESSO, ESTRO, EuropaDonna)","volume":"1","author":"Vaz","year":"2025","journal-title":"EANM J."},{"key":"2026082505101069000_67.8.1201.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.253062"},{"key":"2026082505101069000_67.8.1201.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1116-y"},{"key":"2026082505101069000_67.8.1201.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.163907"},{"key":"2026082505101069000_67.8.1201.33","doi-asserted-by":"crossref","first-page":"3746232","DOI":"10.1155\/2016\/1235429","article-title":"The role of 18F-FDG PET\/CT and MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis","volume":"2016","author":"Liu","year":"2016","journal-title":"Biomed Res Int."},{"key":"2026082505101069000_67.8.1201.34","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1007\/s00330-017-4831-y","article-title":"The accuracy of 18F-FDG PET\/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review","volume":"27","author":"Tian","year":"2017","journal-title":"Eur Radiol."},{"key":"2026082505101069000_67.8.1201.35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00259-018-4194-x","article-title":"Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements","volume":"46","author":"Eskian","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026082505101069000_67.8.1201.36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiol.2021204677","article-title":"Simultaneous FAPI PET\/MRI targeting the fibroblast-activation protein for breast cancer","volume":"302","author":"Backhaus","year":"2022","journal-title":"Radiology."},{"key":"2026082505101069000_67.8.1201.37","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1007\/s13277-015-3594-9","article-title":"Expression of cancer-associated fibroblast-related proteins in adipose stroma of breast cancer","volume":"36","author":"Jung","year":"2015","journal-title":"Tumour Biol."},{"key":"2026082505101069000_67.8.1201.38","first-page":"1","article-title":"Comparison of diagnostic performance of [68Ga]-Ga-FAPI-46 and [18F]-FDG PET\/CT imaging for the detection of lesions and disease staging in patients with breast cancer","volume":"13","author":"Radmehr","year":"2025","journal-title":"Asia Ocean J Nucl Med Biol."},{"key":"2026082505101069000_67.8.1201.39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","article-title":"Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)","volume":"2","author":"Mori","year":"2024","journal-title":"Npj Imaging."},{"key":"2026082505101069000_67.8.1201.40","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026082505101069000_67.8.1201.41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10549-018-4711-4","article-title":"Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer","volume":"169","author":"Miyake","year":"2018","journal-title":"Breast Cancer Res Treat."},{"key":"2026082505101069000_67.8.1201.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1297-4"},{"key":"2026082505101069000_67.8.1201.43","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x"},{"key":"2026082505101069000_67.8.1201.44","doi-asserted-by":"crossref","unstructured":"Al-Ibraheem A Abdlkadir AS Ruzzeh S . [177Lu]Lu-FAPI radioligand therapy: emerging horizons and clinical promise in solid tumors: a comprehensive review. Semin Nucl Med. July 3, 2025 [Epub ahead of print].","DOI":"10.1053\/j.semnuclmed.2025.06.010"},{"key":"2026082505101069000_67.8.1201.45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00259-023-06482-z","article-title":"Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment","volume":"51","author":"Yadav","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026082505101069000_67.8.1201.46","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259192"},{"key":"2026082505101069000_67.8.1201.47","first-page":"241162","article-title":"FRONTIER: FAPi radioligand open-label, phase 1 study to evaluate safety, tolerability and dosimetry of [Lu-177]-PNT6555; a dose escalation study for treatment of patients with select solid tumors [abstract]","volume":"65(suppl 2)","author":"Juneau","year":"2024","journal-title":"J Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:10:29Z","timestamp":1787659829000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.2967\/jnumed.126.272191"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272191","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}